[Familial Mediterranean fever]

Area of Science:

• Genetics
• Immunology
• Molecular Biology

Background:

• Familial Mediterranean Fever (FMF) is a hereditary autoinflammatory disease prevalent in Mediterranean populations.
• Characterized by recurrent episodes of fever, abdominal pain, and inflammation of serous membranes, pleura, joints, or skin.
• Amyloidosis, a severe complication, can lead to end-stage renal disease.

Observation:

• The gene responsible for FMF was identified in 1997 by independent research teams.
• This gene encodes the pyrin/marenostrin protein, crucial for regulating inflammatory processes.
• Key mutations within the pyrin gene have been identified.

Findings:

• The discovery of the FMF gene provides a molecular basis for the disease.
• Identification of specific mutations enables genetic screening for FMF.
• Understanding pyrin's role sheds light on inflammatory pathway dysregulation.

Implications:

• Molecular screening facilitates early diagnosis and targeted treatment of FMF.
• Lifelong colchicine therapy is effective in preventing FMF attacks and complications.
• Genetic insights pave the way for potential novel therapeutic strategies for FMF and related autoinflammatory conditions.